Weitere Kompetenzen
- Durchführung klinischer Studien in der Radioonkologie (Leiter des Studiensekretariats)
- Akademische Lehre für das Fach Radioonkologie (Zertifikat Didaktik in der Medizin)
- MR-Linac basierte Behandlung von Kopf-Hals-Tumoren
- Stereotaktische Radiotherapie
- Kombination von Radiotherapie mit Chemo- oder Antkörpertherapie
- Behandlung und Forschung bei HPV-assoziierten Malignomen
Werdegang
| Seit 01/2021 | Chief of Service, Department of Radiation Oncology, University Hospital Zurich, CH |
|---|---|
| Seit 01/2019 | Clinical lead of the Radiation Oncology department at USZ – CIRCLE |
| Seit 01/2019 | Lead of the Radiation Oncology study office |
| 10/2018 – 12/2020 | Senior Consultant, Department of Radiation Oncology, University Hospital Zurich, CH |
| 01/2015 – 09/2018 | Staff member, SAPHIR radiosurgery – Cyberknife, Schleusenweg 2, Frankfurt, D |
| 11/2013 – 09/2018 | Consultant and Faculty member, Department of Radiotherapy, J.W. Goethe University Frankfurt, D |
| 2016 | Habilitation & Privatdozent in Radiation Oncology, J.W. Goethe University Frankfurt (title: „Radiotherapy for Squamous Cell Carcinoma of the Head and Neck: Biology and Treatment Optimization for Primary and Recurrent Disease“ |
| 07/2008 – 10/2013 | Resident in Radiation Oncology, Department of Radiotherapy, J.W. Goethe University Frankfurt, D |
| 2010 | Doctoral Degree, J.W. Goethe University, Frankfurt, D, Prof. Dr. Bergmann (Onkologie) |
| 10/2001 – 06/2008 | Medical Study, J.W. Goethe University, Frankfurt, D |
Wichtigste Mitgliedschaften
- European Organization for Research and Treatment of Cancer (EORTC)
- European Society of Radiation Oncology (ESTRO)
- Swiss Society of Radiation Oncology (SSRO)
- Swiss Group for Clinical Cancer Research (SAKK)
- German Society of Radiation Oncology (DEGRO)
- Swiss Head and Neck Society (SHNS)
- German Consortium for Translational Cancer Research (DKTK) – RadOnc group
- European Head and Neck Society (EHNS)
- European Academy for Tumor Immunology (EATI)
- German Cancer Society (DKG) and Study Group Radiation Oncology (ARO)
Forschungsschwerpunkte
- Kopf-Hals-Tumoren: klinische multimodale Behandlung, translationale Radioonkologie, Entwicklung neuer Bestrahlungs- und Planungstechniken (MR-Linac, automatische Zielvolumendefinition)
- Behandlung und Biologie HPV-assoziierter Malignome
- Immunologie bei Kopf-Hals und Analkarzinomen
Publikationen
Publikationsliste anzeigenWeiteres
Journal Editorial Board Member
- Frontiers in Oncology: section head and neck tumors
- PloS One
- Cancers
Participation in Guidelines
S2k-guideline basal cell carcinoma (2018)
ESMO-guidelines for treatment of head and neck cancer in times of COVID-19 (2020)
Investigator in clinical trials (selection)
SUPPORTAN (2008-2011) – Phase III, randomized, multicentric trial
BEVXELOX-RT (2008-2009) – Phase II, single-arm, multicentric trial
PACCIS-RT (2010-2015) – Phase IV, randomized, multicentric trial
POLYPROBE (2011) – translational research, multicentric trial
INVERT head&neck (2013) – Phase IV, single-arm, single-centre trial
DÖSAK-pN1 from 2009 – Phase III, randomized, multicentric trial
SOCCER (2013 –2016) multicentric, observation trial
HNprädBio (2013- 2018) – translational research, multicentric trial
CONKO-007 (2013-2018) – Phase III, randomized, multicentric trial
HYPOSIB (2016-2018) – Phase III, randomized, multicentric trial
HYPOSTAT (2016-2018) – Phase II, single-arm, multicentric trial
MARTHA (2019- ongoing) – Phase II, single-arm, unicentric trial
DOSIS-RCT (2019-ongoing) – Phase III, randomized, multicentric trial
IOSI-RTO-001 (2019-ongoing) – Phase II, single-arm, multicentric trial